Sales of most major products slow.

After the medical reform program most of local drug industries put more promotional efforts to non-major drugs in order to overcome severe competitions and thereby marginal growth of their major products.

According to a Yakup Press survey on the list drug companies of fiscal year ended at Dec. 31, most of their major products did not make any growth but rather decline. In fact, more than a h...